glp-1 weight loss results my honest journey GLP-1 Availability for Weight Loss

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously

Tell your healthcare provider if you have any of the following symptoms, which could indicate a problem with your thyroid (Novo Nordisk, 2021): A lump or swelling in your neck Hoarseness Trouble swallowing Shortness of breath It isnt common, but Rybelsus can cause complications for people with certain health conditions including (Novo Nordisk, 2021): Pancreatitis Diabetic retinopathy (damage to the eye from diabetes) Renal (kidney) problems Its not recommended to take this medication while youre pregnant or breastfeeding

In April 2025, Novo announced an additional investment of more than $1 billion to expand its production site in Montes Claros, Minas Gerais, Brazil, with operations expected to begin in 2028

Both health coachingone-to-one support between coach and membersand social supportvia peer communitiesoffer real value to people on their health journeys

Despite this, the FDA advises people with a history of thyroid cancer or a family history of this cancer to avoid GLP-1 drugs

The patient reported appetite suppression immediately after starting semaglutide treatment